Evidence map›Paper›PMID 42572919›Full record

ArticleJournal of extracellular vesicles2026

Tumour-Derived Extracellular Vesicles Containing dsRNA Induce Degradation of Ribosomal Protein mRNA in Platelets.

Gaoge Sun, Yuhuan Tao, Zihan Liu, Kaixiang Zhang, Shuai Zuo, Shanwen Chen, Shufang Ning, Tianyi Zhang, Pengyuan Wang, Ying Zhang and 2 more

Abstract read
In one paragraph

Article in Journal of extracellular vesicles, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Gaoge SunInstitute for Advanced Study, Beijing Normal University, Beijing, China.ORCID 0000-0002-7656-1125
Yuhuan TaoMOE Key Laboratory of Bioinformatics, State Key Laboratory of Green Biomanufacturing, Center for Synthetic and Systems Biology, School of Life Sciences, Tsinghua University, Beijing, China.
Zihan LiuState Key Laboratory of Membrane Biology, School of Pharmaceutical Sciences, Tsinghua University, Beijing, China.
Kaixiang ZhangState Key Laboratory of Membrane Biology, School of Pharmaceutical Sciences, Tsinghua University, Beijing, China.
Shuai ZuoTranslational Cancer Research Center, Division of General Surgery, Peking University First Hospital, Beijing, China.
Shanwen ChenTranslational Cancer Research Center, Division of General Surgery, Peking University First Hospital, Beijing, China.
Shufang NingPrecision Medicine Center, Department of Experimental Research, Guangxi Medical University Cancer Hospital, Nanning, China.
Tianyi ZhangState Key Laboratory of Membrane Biology, School of Pharmaceutical Sciences, Tsinghua University, Beijing, China.
Pengyuan WangKey Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, Beijing, China.
Ying ZhangState Key Laboratory of Membrane Biology, School of Pharmaceutical Sciences, Tsinghua University, Beijing, China.ORCID 0000-0003-3362-3952
Zhi John LuMOE Key Laboratory of Bioinformatics, State Key Laboratory of Green Biomanufacturing, Center for Synthetic and Systems Biology, School of Life Sciences, Tsinghua University, Beijing, China.ORCID 0000-0003-4751-9400
Hang Hubert YinInstitute for Advanced Study, Beijing Normal University, Beijing, China.ORCID 0000-0002-9762-4818

Funding

Beijing Natural Science Foundation IS23100Beijing Natural Science Foundation IS23107Beijing Outstanding Young Scientist Program BJJWZYJH01201910003013Capital's Funds for Health Improvement and Research 2024-4-40711Joint Research Project of the Shijiazhuang-Peking University Cooperation ProgramNational High Level Hospital Clinical Research FundingNational Key Research and Development Program of China 2023YFC3605400National Key Research and Development Program of China 2024YFC2510300National Key Research and Development Program of China 2024YFC3405902National Natural Science Foundation of China 22137004National Natural Science Foundation of China 22541704National Natural Science Foundation of China 32170671National Natural Science Foundation of China 82341101National Natural Science Foundation of China 82371855National Natural Science Foundation of China 82430109National Natural Science Foundation of China T2541067Noncommunicable Chronic Diseases-National Science and Technology Major Project 2023ZD0501500Tsinghua University Initiative Scientific Research Program of Precision Medicine 2022ZLA003Youth Clinical Research Project of Peking University First Hospital 2025YC07
6 · The paper itself

Abstract

Extracellular vesicles (EVs) mediate intercellular communication within the tumour microenvironment by carrying cargoes from paracrine parent cells. EVs have attracted great research interest for their ability to carry nucleic acids into recipient cells and modulate cellular functions. However, previous studies have largely focused on RNA sequence information rather than RNA structure features. Here, we observed that EVs derived from colorectal cancer cells are enriched with endogenous double‑stranded RNA (dsRNA), a danger‑associated molecular pattern (DAMP) that leads to the activation of dsRNA‑sensing pathways in recipient cells. Crucially, we investigated the specific crosstalk between tumour-derived EVs and circulating platelets. As anucleate cells, platelets are uniquely suited models for isolating the effects of exogenous nucleic acids. Our analysis reveals that endogenous dsRNA from tumour EVs activates the platelet OAS-RNASEL innate immune ribonuclease cascade and the RNASEL/ABCE1/PELO axis, resulting in the decay of ribosomal protein mRNAs. This study, spanning from clinical observation to mechanistic validation, uncovers a novel pathway of tumour-platelet communication. We identify EV-enriched endogenous dsRNA as a functional mediator that enables tumour cells to directly reprogram platelet transcriptomes, revealing a new dimension of tumour-immune modulation.

Indexed as

Blood PlateletsColorectal NeoplasmsExtracellular VesiclesRibosomal ProteinsRNA, Double-StrandedRNA, MessengerCell Line, TumorHumansRNA StabilityTumor MicroenvironmentRibosomal ProteinsRNA, Double-StrandedRNA, Messengerdouble‐stranded RNAextracellular vesiclesplateletsribosomal protein mrna

Identifiers

PMID42572919
PMCPMC13454952

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.